Best Wearable Technology Companies in San Diego, United States

Provider of a wearable biosensor platform for diabetes monitoring. It offers a wireless microsensor that enables users to understand their metabolism and blood glucose levels in real-time.

Funding rounds

• Mar 2025Series C$100M
• Dec 2023Series B$59.1M
• Nov 2021Series B$100M
• Sep 2021Grant (prize money)$1.9M

Founders & team

Jared TangneyCo-FounderRichard YangCEO

Investors

M Ventures, Hikma Ventures, Three Leaf Ventures, LifeSci Venture Partners, GSVP, Alpha Wave Global

Tech stack

Google AnalyticsGreenhouseJqueryJsdelivrLottiefilesOpen Graph

Advanced Brain Monitoring develops mobile EEG hardware and software, integrating, analyzing and reporting multi-sensor data. The company offers B-Alert EEG Software, X-Series EEG Headsets, Sleep Profiler (to detect sleep-disordered breathing in the home), InsomniCare (web-based solution for diagnosis & treatment of chronic insomnia). The company received FDA clearance for its X-Series System.

Innovating dry EEG sensors and psychophysiological monitoring systems for diverse applications. They are a global leader in noninvasive biosensing systems, specializing in dry sensors for high-fidelity psychophysiological monitoring without gels or sticky pads. Their advanced technology integrates precision hardware with sophisticated algorithms, outputting actionable information about cognitive and physiological states. They build psychophysiological sensing systems to spec and design algorithms that output precise, useful metrics. They offer solutions for human performance, healthcare, and commercial applications, including ambulatory cognitive state evaluation, seizure detection, and integration into wearable devices. Their expertise spans EEG, ECG, EMG, EOG, Pulse Oximetry, respiration, and inertial motion units. They provide unified data streams, eliminating integration headaches and reducing sources of error in physiological monitoring and analysis. They work with both government and commercial organizations to turn concepts into systems, offering expertise from research systems to medical devices.

Funding rounds

• Jan 2025Grant (prize money)$500K
• Jan 2025Grant (prize money)$500K
• Jul 2014Grant (prize money)$119K
• Nov 2009Grant (prize money)$147.6K

Founders & team

Walid SoussouCEO

Investors

National Science Foundation, HHS

Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema. The company has developed a UV therapy based device that facilitates the treatment of chronic skin conditions. It uses advanced phototherapy technology that delivers a precise dose of light on the skin for treating multiple skin diseases. Its ultraviolet B (NB-UVB) light can penetrate the skin, and prevent the growth of affected skin cells for psoriasis. It also offers an integrated mobile app for the visualization of results.

Funding rounds

• Oct 2021Series B$43M
• Nov 2019Series A$2.6M
• Nov 2019Series A$18M
• Dec 2017Seed$1M

Founders & team

Lisa RCEO

Investors

EvoNexus, 7wire Ventures, SV Health Investors, Bluestem Capital, H.I.G. HealthBridge, General Catalyst

Tech stack

Amazon SesAmazon Web ServicesAosApple Icloud MailCdnjsCloudflare

Provider of a wearable device for glucose monitoring. It provides a wearable patch that enables users to measure glucose levels in real-time. It has the capability to send data wirelessly to a display device through a transmitter and the touch screen receiver displays real-time glucose data. In 2022, the company recorded annual revenues of $3.02B and a net profit of $0.29B.

Funding rounds

• Apr 2020Post IPO$1.1B
• Dec 2018Post IPO$850M
• May 2016Post IPO$7.2M
• Sep 2014Grant (prize money)$224.4K

Founders & team

Kevin SayerCEO & President

Investors

Canaan, RWI Ventures, Invesco Mutual Fund, Warburg Pincus, HHS, Black Diamond Ventures

Tech stack

Acquia Cloud PlatformAmazon CloudfrontAmazon S3Amazon Web ServicesAmplienceAngular

GlySens Incorporated, a biomedical technology company, that develops implantable continuous glucose monitoring devices. Its device indicates the current blood glucose level, shows a historical chart of the previous blood glucose values, provides adjustable automatic warnings of high and low blood glucose readings, and stores. The GlySens fully implanted sensor demonstrated up to 18 month lifetime in preclinical testing, links wirelessly to an external receiver and provide continuous glucose measurement, recording, and alerts regarding hypo- and hyperglycemic glucose excursions.

Funding rounds

• Jun 2020Unattributed$15M
• Dec 2015Unattributed$20M
• Jan 2015Unattributed$12M
• Nov 2014Grant (prize money)$2M

Founders & team

William MarkleCEO

Investors

NIDDK, McNair, Fayez Sarofim, West Health, HHS, Windham Venture Partners

Medtronic Diabetes: Innovative solutions for diabetes management and insulin delivery. They are dedicated to transforming diabetes care through advanced technology and comprehensive support. They offer a range of products and services, including smart insulin pens, continuous glucose monitoring systems, and insulin pump therapy. Their solutions aim to simplify diabetes management, improve glycemic control, and enhance the quality of life for individuals living with diabetes. They provide resources for healthcare professionals, patients, and caregivers, including product training, user guides, and community support. They focus on innovation, accessibility, and personalized care to empower people to live healthier, more fulfilling lives. They are committed to advancing diabetes technology and improving outcomes for individuals worldwide. They offer digital logbook, dose calculator, and mobile app. They are B2C and B2B company.

Funding rounds

• Jan 2020Conventional Debt$27.5M
• Apr 2018Series B$14.1M
• Nov 2017Series B$1.8M
• Dec 2016Conventional Debt$1M

Founders & team

Sean SaintCEO & President

Investors

K2 HealthVentures, Diamyd Medical, MedVenture Partners, Octane, Synergy Ventures

Tech stack

DrupalPhpOpensslApache Http ServerHstsDigicert

Exoskeleton technology improving worker musculoskeletal health, productivity, and reducing fatigue. They are an engineering company focused on wearable technology designed to improve upper extremity musculoskeletal health for workers. Their AIRFRAME® is a lightweight, customizable exoskeleton that moves seamlessly with the user, enhancing productivity and reducing shoulder injury risk. This innovative solution addresses worker fatigue in industries involving repetitive motion. The company's technology offers a tangible benefit by supporting prolonged work activities without fatigue, improving overall safety and well-being. They are committed to providing advancements in personal protective equipment.

Internet first brand offering digital audio wearable technology products. Their product catalog includes MyBeam, an audio beamforming technology that delivers personal audio communication without a headset for conferencing and entertainment. They also provide beamforming services for consumer electronic speakers and headset OEMs, enterprise TEMs, kiosk system manufacturers and integrators, and gaming platforms.

Tensys Medical develops and commercializes continuous, non-invasive, hemodynamic monitoring systems. Its technology is both FDA approved and CE Mark approved. The technology is used in Hospitals in areas like the operating room, ICUs, and Electrophysiology labs to provide a patient's real-time pulse pressure waveform and blood pressure. This technology is able to measure these parameters without a needlestick.

Developer of a non-invasive glucose monitoring device. The company develops a non-invasive glucose meter that measures glucose from the conjunctiva of the eye. it does not require contact with the eye and simply points the sensor at the eye and clicks. The glucose sensor is the size of a cell phone.

Funding rounds

• Dec 2005Series A$7.3M

Founders & team

W. Tate Scottex-CEO

Investors

Shepherd Ventures, ONSET Ventures, CHL Medical Partners, Canaan, Three Arch Partners

Motorcycle Head-Up Display: Navigation, communication, action camera, and music, all integrated into a single helmet-mounted device. This innovative technology streamlines the riding experience by consolidating multiple functions, reducing distractions, and enhancing focus on the road. It offers navigation with turn-by-turn directions, music streaming from various platforms, photo and video capture, and seamless communication through an integrated headset. The accompanying app allows users to plan routes, save rides, access photos, and review riding statistics. This all-in-one solution provides a distraction-free, connected journey, enabling riders to concentrate solely on the ride. It is a B2C product.